3633 results for «684»
3633 results
What bench testing teaches us about real world PCI
19 May 2026 – From EuroPCR 2026
This session explores bench testing insights into real-world percutaneous coronary interventions (PCI). Topics include comparative expansion ratios of coronary stents, prognostic assessments after drug-coated balloon treatments, mechanical performance of magnesium scaffolds in bifurcations, preclinical safety and computational modeling of bioresorbable polymer-coated stents, and evaluations of commonly...
Complication management in CTO PCI - Part 1
19 May 2026 – From EuroPCR 2026
This session addresses complication management during chronic total occlusion (CTO) percutaneous coronary interventions. It covers strategies for unexpected coronary complications, managing tamponade without visible perforation, rescue techniques for atherectomy-related perforations, managing dry pericardial tamponade after septal branch perforation, and challenges when retrograde approaches encounter thrombosis in...
CTO PCI: technical developments
19 May 2026 – From EuroPCR 2026
This session highlights technical developments in CTO PCI, featuring comparative insights from the ONUBA-CTO study on retrograde versus antegrade approaches, sex-based differences in long-term outcomes, management of balloon-undilatable lesions, the role of virtual reality audiovisual distraction, the impact of core laboratory feedback with OCT, and contemporary...
Behind standard practice: a place for DCB
19 May 2026 – From EuroPCR 2026
This session examines the role of drug-coated balloons (DCB) beyond standard practice in coronary revascularization. It includes discussions on revascularization strategies in young patients, rescue of early distal LIMA–LAD anastomosis, treatment of in-stent restenosis, stepwise complex CTO bifurcation revascularization using kissing DCBs, and management of calcified...
Mitral TEER beyond the routine: complex and complicated cases
19 May 2026 – From EuroPCR 2026
This session explores complex and complicated cases of mitral transcatheter edge-to-edge repair (TEER) beyond routine practice. It addresses challenges such as device failures, late complications, acute left ventricular dysfunction related to afterload changes, stepwise approaches to overcome procedural failures, rescue strategies in cardiogenic shock, and tailored...
Interventions for heart failure: insights and innovations
19 May 2026 – From EuroPCR 2026
This session presents innovations and insights into interventional treatments for heart failure. Topics include pulmonary artery denervation for combined pre- and post-capillary pulmonary hypertension, evaluation of extravascular ventricular assist devices, biomarker-guided therapy withdrawal in improved heart failure, outcomes of transcatheter iatrogenic atrial shunts, percutaneous balloon pericardiotomy...
PCI for complex left main disease
19 May 2026 – From EuroPCR 2026
This session delves into the complexities of percutaneous coronary intervention (PCI) for left main disease, emphasizing strategic approaches to dual critical lesions and innovative techniques such as excimer laser and drug-eluting balloons. It also explores hybrid strategies for treating in-stent restenosis and redo revascularisation, offering a...
PCR's Got Talent Round 1 - Session 2
19 May 2026 – From EuroPCR 2026
PCR's Got Talent Round 1 - Session 2 offers a diverse collection of studies addressing coronary microvascular dysfunction, atrial fibrillation management, TAVI outcomes, AI applications in imaging, mitral and tricuspid valve interventions, and in-stent restenosis treatment. The session culminates with deliberations and results announcements, reflecting cutting-edge...
AI for clinical and academic cardiology knowledge work: innovation or academic misconduct ? Literature search, data extraction and responsible use
19 May 2026 – From EuroPCR 2026
This session critically examines the role of artificial intelligence in clinical and academic cardiology, focusing on its application in literature search, evidence synthesis, and report structuring. It discusses responsible AI use, emphasizing the balance between assistance and academic integrity, and features a debate on authorship, transparency,...
Artificial intelligence and advanced imaging in coronary interventions
19 May 2026 – From EuroPCR 2026
This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...
TAVI procedural complications - Part 4: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses a spectrum of procedural complications encountered in TAVI, focusing on vascular issues, coronary challenges, and device-related difficulties. Case presentations include partial prosthesis expansion, emergency thoracic aortic stenting, repeat balloon valvuloplasty, revascularization dilemmas, and complex valve-in-valve procedures. The discussion provides practical perspectives on managing...
Complex transfemoral TAVI: how to manage the root to success
20 May 2026 – From EuroPCR 2026
Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.
Vascular access: femoral and radial
20 May 2026 – From EuroPCR 2026
This session explores vascular access techniques in interventional cardiology, emphasizing both femoral and radial approaches. It covers access-related bleeding and ischemic complications, safety and efficacy of distal radial programs, and innovations in sheath technology. Additional topics include post-procedural mobilization, management of radial artery recanalization, balloon fenestration...
Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)
21 May 2026 – From EuroPCR 2026
This session reviews pivotal recent evidence impacting daily practice in coronary artery disease management. It discusses the role of drug-coated balloons (DCB) for de novo lesions as evaluated in the SELUTION trial and evaluates intracoronary imaging strategies for left main PCI as presented in the OPTIMAL...
Novel indications for DCB
21 May 2026 – From EuroPCR 2026
This session reviews emerging clinical applications for drug-coated balloons (DCB) beyond traditional indications. It covers outcomes in venous stenosis, aorto-ostial lesions, and coronary bifurcation disease, comparing DCB strategies with drug-eluting stents and highlighting recent clinical trial findings.
Optimising the results of non-left main bifurcation PCI
21 May 2026 – From EuroPCR 2026
This session focuses on optimizing outcomes in non-left main bifurcation PCI by emphasizing lesion preparation and stent sizing guided by intravascular imaging. It integrates physiological and imaging assessments for confident final result evaluation and discusses criteria for selecting upfront two-stent strategies in bifurcation lesions.
A new horizon in left main and multivessel PCI
21 May 2026 – From EuroPCR 2026
This session explores new horizons in managing left main and multivessel coronary artery disease with PCI. It covers comprehensive evaluation techniques, including physiology and imaging assessments, and advanced PCI strategies for challenging eccentric and heavily calcified lesions. Case presentations from diverse clinical contexts illustrate decision-making and...
Advancing TAVI practice
21 May 2026 – From EuroPCR 2026
Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.
TAVI procedural complications - Part 7: coronary protection, valve embolisation, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications in TAVI, featuring challenging cases such as rupture of the sinus of Valsalva, innovative bailouts for valve embolisation, mechanisms of aorta-right ventricular fistula post-TAVI, and management strategies for failed surgical aortic valves after endocarditis.
TAVI interventions for all? From congenital bicuspid valve towards valve-in-valve challenging cases
21 May 2026 – From EuroPCR 2026
This session delves into the complexities of TAVI interventions across diverse challenging cases, including congenital bicuspid valves and valve-in-valve scenarios. It emphasizes complication prevention, decision-making for the Unicorn technique, and the critical role of pre-procedural imaging, illustrated through detailed case studies from Estonia, the Netherlands, and...